Newsroom
Link to: Client news
Client news
The latest news from Optimum clients
Follow a manual added link
Conference
Optimum’s 16th Annual Healthcare Investor Conference
Follow a manual added link
Weekly wrap-up
Read Optimum’s round-up for the low-down on client and industry news
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
/in Client newsThis week’s hot topic: Biopharma investment market bullish ahead of Optimum’s annual conference
/in InsightsSTORM Therapeutics to Present Phase 1 Data on its First-in-Class Lead Product STC-15 at EORTC-NCI-AACR Symposium
/in Client newsAntag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687
/in Client newsCurve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer
/in Client newsOptimum Strategic Communications to Host 16th Annual Healthcare Investor Conference with ‘Back to Growth’ theme
/in Insights, Optimum newsAdcendo Announces US FDA Clearance of IND Application for Phase I/II First-in-Human ADCElerate-01 Trial of ADCE-D01 (uPARAP Receptor Targeting ADC) Trial in Patients with Metastatic and/or Unresectable Soft Tissue Sarcoma (STS)
/in Client newsWeekly wrap-up: Optimum’s 16th Annual Healthcare Investor Conference is almost upon us!
/in InsightsThis week’s hot topic: prime editing moves closer to patients
/in InsightsResolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment
/in Client newsOptimum’s 16th Annual Healthcare Investor Conference 2024
/in InsightsSector updates in September
/in InsightsLoQus23 Therapeutics announces £35 million (c.$43 million) Series A financing to advance its small molecule somatic expansion inhibition therapy for Huntington’s disease
/in Client newsCurve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board
/in Client newsHeidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
/in Client news